Patel Snehal
Greenwich LifeSciences, Inc. · CEO and CFO
Patel Snehal is listed in filings as CEO and CFO at Greenwich LifeSciences, Inc.. This profile follows SEC Form 4 activity through Jan 15, 2026, including purchase activity. Recent filings connect the profile to Greenwich LifeSciences, Inc. (GLSI). The current snapshot covers public activity from Nov 28, 2025 to Jan 15, 2026. Reported amounts are shown as $38.5K to $63.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $39k4.6k shares | BuyNov 25, 2025 | $8.37 | $16.32 | |
| $52k4.1k shares | BuyDec 18, 2025 | $12.62 | $16.32 | |
| $63k2.9k shares | BuyDec 30, 2025 | $21.73 | $16.32 | |
| $92k4.3k shares | BuyDec 31, 2025 | $21.36 | $16.32 | |
| $80k2.9k shares | BuyJan 12, 2026 | $27.54 | $16.32 |